Jeffrey Kaye, M.D., professor and director of OHSU’s Layton Aging and Alzheimer’s Disease Center, will lead the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) this year, following his service as vice chair of the society for the past two years.
“I am honored to be leading this international professional society of Alzheimer’s researchers, and I look forward to continuing to work to find treatment and ultimately a cure for this devastating disease,” Dr. Kaye said.
ISTAART is a professional society for individuals interested in Alzheimer’s and dementia science, including scientists, physicians and other professionals involved in the causes and treatments of Alzheimer’s disease and other dementias.
“We are delighted Dr. Kaye will be leading ISTAART,” said Tracy Morgan, interim executive director of the Alzheimer’s Association Oregon Chapter. “His knowledge and expertise have benefited Alzheimer’s research in Oregon — and around the world.”
Dr. Kaye is the Layton Endowed Professor of neurology and biomedical engineering at OHSU’s Layton Aging & Alzheimer’s Disease Center. He is director of the center as well as the director of the Oregon Center for Aging and Technology. His research focuses on understanding healthy aging using a variety of approaches ranging across the fields of genetics, neuroimaging, physiology and continuous activity monitoring. He leads several longitudinal studies of aging, including the ongoing Oregon Brain Aging Study and the Intelligent Systems for Detection of Aging Changes (ISAAC) study using pervasive computing technologies for continuous assessment of health and function among the aging in their homes.
Dr. Kaye has received the Charles Dolan Hatfield Research Award for his work. He is listed in Best Doctors in America and serves on many national and international panels and review boards in the fields of geriatrics, neurology and technology. Dr. Kaye is an author of more than 300 scientific publications and holds several major grant awards from federal agencies, national foundations and industrial sponsors.
